GWLL
GOLDENWELL BIOTECH, INC.
Key Financials
Gross Profit
$64
↓ 94.2%
Net Income
$-131498
↓ 12.5%
Revenue
$139
↓ 92.4%
Operating Income
$-123098
↓ 5.3%
EPS (Diluted)
$0.00
NaN%
Cash & Equivalents
$45996.00
↓ 78.5%
Shareholders' Equity
$-47241.00
↓ 155.8%
Total Liabilities
$271433.00
↑ 89.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 5/27/2026 | View on SEC |
| NT 10-Q | 5/12/2026 | View on SEC |
| NT 10-K | 3/31/2026 | View on SEC |
| 10-Q | 12/8/2025 | View on SEC |
| 10-Q | 9/12/2025 | View on SEC |
| 8-K | 8/19/2025 | View on SEC |
| NT 10-Q | 8/14/2025 | View on SEC |
| 10-Q | 5/27/2025 | View on SEC |
| 10-K | 5/15/2025 | View on SEC |
| NT 10-Q | 5/14/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | GWLL |
| Company Name | GOLDENWELL BIOTECH, INC. |
| CIK | 1800373 |
| Sector | Food and Kindred Products |
| Industry | Emerging growth company |
| Exchange | OTC |
| SIC Code | 2000 |
| SIC Description | Food and Kindred Products |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | 440-666-7999 |